Wednesday, September 24, 2008 — The UNC Lineberger Comprehensive Cancer Center has received a two-year, $125,000 grant to support clinical trials in gastrointestinal (GI) cancers.
Wednesday, September 24, 2008 — University of North Carolina at Chapel Hill researchers will play a key role in a five-year, $8.9 million study aimed at understanding the impact hearing loss can have on children’s ability to communicate, succeed in school, and have good social and psychological development.
September 23, 2008 — Joel E. Tepper, M.D., professor of radiation oncology at the University of North Carolina at Chapel Hill School of Medicine, is being honored by the American Society of Therapeutic Radiology (ASTRO) as one of two recipients of the organization’s Gold Medal Award.
September 17, 2008 — Researchers at the University of North Carolina at Chapel Hill School of Medicine have transformed cells from human skin into cells that produce insulin, the hormone used to treat diabetes.
September 17, 2008 — Among people who have had an initial colonoscopy that found no polyps, a possible sign of cancer, the risk of developing colorectal cancer within five years is extremely low, a new study has found.
September 16, 2008 — Brian D. Strahl, Ph.D., associate professor of biochemistry and biophysics at the University of North Carolina at Chapel Hill School of Medicine, is one of 38 scientists nationally to receive the first grants in a new federal program called EUREKA (Exceptional, Unconventional Research Enabling Knowledge Acceleration).
September 15, 2008 — The University of North Carolina at Chapel Hill is leading a novel clinical trial to compare the effectiveness of online cognitive behavioral therapy, delivered through a Web site and augmented with therapist-moderated, weekly online chat sessions, to face-to-face group therapy for the treatment of bulimia nervosa.
September 15, 2008 — Nearly every child who receives an antipsychotic medicine is first prescribed one of the second-generation, or “atypical” drugs, such as olanzapine and risperidone. However, there has never been evidence that these drugs are more effective than the older, first-generation medications.
September 11, 2008 — Cancer, Parkinson’s disease, Alzheimer’s, stroke – biomedical researchers at the University of North Carolina at Chapel Hill will be able to make strides in understanding and treating all of these diseases and more because of a $260 million investment to enhance the University’s imaging capabilities.
September 5, 2008 — A University of North Carolina at Chapel Hill spin-off company has been awarded a $2 million grant to commercialize a new technology to improve radiation treatment of prostate cancer.
September 4, 2008 — A nationwide team of scientists, including researchers at the University of North Carolina at Chapel Hill’s Lineberger Comprehensive Cancer Center, have reported the first results of a large-scale, comprehensive study of the most common form of brain cancer, glioblastoma.
September 3, 2008 — Newly published results from a clinical trial show that laser surgery is more effective at preserving eyesight in diabetics and has fewer side effects than steroid injections.
September 2, 2008 — Almost half of all U.S. adults and nearly two-thirds of obese adults will develop painful osteoarthritis of the knee by age 85, a study based at the University of North Carolina at Chapel Hill suggests.
September 2, 2008 — University of North Carolina at Chapel Hill researchers have demonstrated that a drug called ondansetron helps reduce vomiting, the need for intravenous fluids and hospital admissions in children with acute gastroenteritis.